[Summary] 为全球肿瘤患者带来更好的治疗方案
宜联生物成立于2020年,是一家专注于开发创新型偶联药物的临床阶段生物科技公司。公司开发的新一代具有自主知识产权的肿瘤微环境可激活的新型毒素连接子平台技术(TMALIN®)可实现高DAR值高均一性的稳定偶联,有助于提高ADC药物在实体瘤适应症上的治疗窗。公司致力于以未满足的临床需求为目标,为全球肿瘤患者带来更好的治疗方案。宜联生物位于中国苏州,并在中国上海、美国波士顿建立研发分支机构。
What does 苏州宜联生物医药有限公司 require? Who is 宜联生物 hiring? 宜联生物 recruitment: 生物/制药/化工/环保类占比最多占56.6%,其次是科研类占26.2%. What education can get in at 宜联生物? 本科占比最多占31.1%,其次是不限占24.7%. High education required at 宜联生物? 硕士占21.7%,博士占21.7%. Work experience required at 宜联生物? 不限占比最多占55.1%,其次是5-10年占17.2%. Where are the job locations at 宜联生物? 苏州占比最多占80.9%,其次是上海占12%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows